Running a successful biologics R&D program is a fundamental challenge in the pharmaceutical industry. The work is highly complex, iterative, and involves developing completely new technology platforms. But successful R&D can lead to highly safe and efficacious therapies with lasting patent protection.Industry executives and thought leaders will gather for an exclusive dinner discussion to share their vision and exchange best practices on how to maximize the success of biologics R&D programs.
The focus will be on organizing, optimizing, and measuring R&D to accelerate time to IND. Attendees will be able to leave the event better informed about how leading companies:
Monitor R&D progress across pipelines to improve strategic prioritization
Overcome the challenge of losing institutional knowledge to industrialize R&D productivity and innovation
Make R&D measurable and data-driven across the R&D lifecycle from discovery to bioprocessing